Search

everythinglearnresearchcommunity

for

Search:↓

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

People from iodine-deficient areas are more likely to develop hypothyroidism when treated for multi-drug resistant tuberculosis.

Flutamide, an oral anti-androgen therapy, is effective in treating female pattern hair loss, even without systemic androgen excess.

Adjusting minoxidil dosage may be safer than using bicalutamide for hair loss in women.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Methotrexate is effective and well-tolerated in children for certain skin conditions but requires careful monitoring.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Nilotinib can cause keratosis pilaris, a skin condition.

Cyclophosphamide helped 59.4% of children with steroid-resistant nephrotic syndrome but caused side effects in 40.6%.

Nilotinib can cause skin issues like red bumps and hair loss.

A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Finasteride may affect PNMT, causing side effects.

Bicalutamide can reduce female pattern hair loss, especially in those with certain conditions, but has limited effects on other hair loss types.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Flutamide and CPA are more effective than finasteride for treating acne in hyperandrogenic women.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Intravenous cyclophosphamide effectively treated steroid-resistant lupus cystitis and peritonitis.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

Bicalutamide may take longer to work for female hair loss, and higher doses might be needed.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.